Tryptamine Therapeutics Limited’s Acquisition and Backdoor Listing of Tryp Therapeutics

Hamilton Locke advised Tryptamine Therapeutics Limited on the deal.Tryptamine Therapeutics Limited secured the acquisition and backdoor listing of Tryp Therapeutics Inc., a biotechnology entity previously listed…

This content is for Standard 1 Year members only.
Login Join Now
Maha Kanaan

Author: Maha Kanaan

This content is for Standard 1 Year members only.
Login Join Now